Table II.
Diagnosis of lesions excised or empirically treated included in the study
| Excised lesions | Excised just after RCM | Nonsurgically treated after RCM | Excised during follow-up |
|---|---|---|---|
| Valid | |||
| Basal cell carcinomas | 39 | 10 | 1 |
| Melanomas* | 30 | — | 2 |
| Severely dysplastic nevi | 7 | — | — |
| Dysplastic/inflamed nevi | 34 | — | 2 |
| Spitzoid neoplasms | 9 | — | — |
| Squamous cell carcinomas | 6 | — | — |
| Actinic keratoses | 11 | — | — |
| Melanocytic nevi | 7 | — | — |
| Lentigines | 2 | — | — |
| Seborrheic keratoses | 3 | — | — |
| Lichenoid keratosis | 4 | — | 1 |
| Angiofibroma | 2 | — | — |
| Inflammation | 3 | — | — |
| Clear cell acanthomas | 2 | — | — |
| Scar | 1 | — | — |
| Ruptured cyst | 1 | — | — |
| Epidermolytic acanthoma | 1 | — | — |
| Subtotal | 162 | 10 | 6 |
| Total | 178 | ||
RCM, Reflectance confocal microscopy.
*
Melanoma characteristics: 1 metastatic, 23 in situ, 8 invasive (median Breslow thickness, 0.35 mm; range, 0.2–0.95 mm).